Research & Development: Page 93
-
Integrating Outcomes Studies Into Medical Education
August 2006 VIEW on Medical Education Outcomes measurement Integrating Outcomes Studies Into Medical Education CME LLC, Irvine, Calif., is dedicated to providing high-quality, life-long learning opportunities for clinicians through a variety of convenient learning formats. For more infor...
By PharmaVoice Team • Jan. 2, 2008 -
Solutions to Bridging the Cross-Cultural Divide in Healthcare
Solutions to Bridging the Cross-Cultural Divide in Healthcare Program Development Sudler & Hennessey AnneMarie Armani, M.D. Senior Medical Director, Imprint Science Daria Blackwell Consultant, Sudler Multicultural Education Ruben Gutierrez Director, Sudler Multicultural Education ...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty ImagesTrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
Why Physicians Learn
Why Physicians Learn Program Development David St. Peter, M.D., Executive VP/Managing Director Customer insights, such as having unique perspectives into what motivates an audience to learn, are critical to the development of successful programs that effectively change behavior. Some may s...
By PharmaVoice Team • Jan. 2, 2008 -
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors
Building a Successful Partnership Between Medical Education Companies and Recruitment Vendors Partnerships Judy Hagan General Manager and Senior VP of Sales and Marketing Having weathered the changing landscape of CME, it has become abundantly clear that MECs c...
By PharmaVoice Team • Jan. 2, 2008 -
Measuring Educational Outcomes in CME
August 2006 VIEW on Medical Education Postgraduate Institute for Medicine Outcomes measurement Measuring Educational Outcomes in CME Jan Schultz, RN, MSN Director, Educational Outcomes and Accreditation Michael R. Lemon, MBA President Commercial supporters want their grant dollar...
By PharmaVoice Team • Jan. 2, 2008 -
Making the Ordinary Satellite Symposium Extraordinary
Making the Ordinary Satellite Symposium Extraordinary Fission Communications Event Planning Mario R. Nacinovich Jr. Senior VP, Chief Creative Officer James A. Karcher Senior Director, Strategic Planning and Business Development Richard L. Abbot Jr. Group Business Director Th...
By PharmaVoice Team • Jan. 2, 2008 -
The Researchers & Scientists
Dr. Daniel P. Getman A Scientific Home Run A leading scientist and a respected spokesperson, Daniel Getman, Ph.D., is a strong advocate for the value of pharmaceutical innovation. His extensive insight into medicinal chemistry has made Dr. Getman, VP of global research and development, director, ...
By PharmaVoice Team • Jan. 2, 2008 -
The Technologists
These technology leaders are taking computer-based and enabled solutions to the next plateau and in doing so they are reducing the time needed to conduct clinical trials, cutting the cost of clinical development, and ensuring that the products that do make it to market are properly evaluated for ...
By PharmaVoice Team • Jan. 2, 2008 -
The Mentors
The Mentors These outstanding individuals unselfishly give of their time and provide their insights to mentor the next generation of business leaders. July/August 2006 PharmaVOICE 100 Kathleen Case Paddling in One Direction For Kathleen Case, directing a group of 23 professionals as her first for...
By PharmaVoice Team • Jan. 2, 2008 -
Cover
100 of the most inspiring people July/August 2006 PharmaVOICE pharmavoice.com Volume 6 Number 7 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
The Change Agents
The Change Agents Not content with the status quo, these individuals have decided to shift the paradigm in their fields and are impacting business processes, technologies, and strategies across the life-sciences industry. Mark Bard Keeping the Focus on Results Education B.S. in health administrat...
By PharmaVoice Team • Jan. 2, 2008 -
Who's on the List -- 2006
Indexed by Section The Commanders and Chiefs Carol Ammon Diana Anderson, Ph.D. John Benbrook Mark Booth Kurt Brykman Thomas Buckley John J. Campbell William Clapper William Claypool, M.D. Nicholas Colucci William H. Crown, Ph.D. Phil Deschamps Susan Desmond-Hellmann, M.D. Fereydoun Firouz Ginger ...
By PharmaVoice Team • Jan. 2, 2008 -
Who's on the List -- 2006
AbelsonTaylor Jay Carter Advanced Health Media Kevin McMurtry Algorithmic Research Inc. Gadi Aharoni, Ph.D. Ambit Biosciences M. Scott Salka Amgen Inc. Kevin Sharer Amylin Pharmaceuticals Inc. Ginger Graham Archives of Internal Medicine and Archives of Dermatology Patricia Quilty AstraZeneca Barr...
By PharmaVoice Team • Jan. 2, 2008 -
Table of Contents
The Commanders and Chiefs Steering a company in the right direction is no easy task in today’s highly regulated and competitive environment. These individuals wear the mantle of responsibility well and are the guiding forces of ethics, good corporate citizenship, and strategic vision for their co...
By PharmaVoice Team • Jan. 2, 2008 -
The PharmaVOICE 100 - Letter from the Editor
What you don’t see in this caricature are the hundreds of moving parts that have to come together to publish this special publication of PharmaVOICE, our second annual issue honoring the 100 most inspiring people in the industry. For all of those parts (and people) I am extraordinarily grateful. ...
By Taren Grom • Jan. 2, 2008 -
Overcoming the Challenges of Clinical Trials in Community-Based Practices
AmerisourceBergen Specialty Group Overcoming the Challenges of Clinical Trials in Community-Based Practices Sharon Jameson, RN, BSN, MBA VP, Clinical Research International Oncology Network, an AmerisourceBergen Specialty Group company Clinical trials in community-based practices al...
By PharmaVoice Team • Jan. 2, 2008 -
Marketplace
Featured Product and Service Showcases AmerisourceBergen Specialty Group Ateb Inc. BioCor Campbell Alliance The Clinical Trial Company Clinlogix Cognos Criterium Inc. D. Anderson & Company Data Communiqué International DVC HealthCare ePharmaceuticals etrials Worldwide Inc. I...
By PharmaVoice Team • Jan. 2, 2008 -
Phase IV Trials -- Improving Product Life After Approval Through Technology
Phase IV Trials — Improving Product Life After Approval Through Technology John M. Hudak, President and Founder It can be theorized that some of the most important research on pharmaceutical products begins after approval. Increasing the commercial applications of an already approved drug ...
By PharmaVoice Team • Jan. 2, 2008 -
Revolutionizing Patient Recruitment: Key Issues and Trends
Revolutionizing Patient Recruitment Key Issues and Trends Diana L. Anderson, Ph.D., President and CEO Revolutionizing patient recruitment requires a commitment by all stakeholders to challenge the status quo and search for new and innovativ...
By PharmaVoice Team • Jan. 2, 2008 -
Global Clinical Trials: Challenge or Opportunity?
Global Trials June 2006 VIEW on Clinical Services Global Clinical Trials: Challenge or Opportunity? Ed Ikeguchi, M.D., Cofounder and Chief Medical Officer Sponsors are realizing that the ROI of EDC and global clinical trials comes not just from the implementation o...
By PharmaVoice Team • Jan. 2, 2008 -
Patient Retention and the Power of Praise
Patient Recruitment VIEW on Clinical Services June 2006 Patient Retention and the Power of Praise Anna LeGoff,VP, Patient Retention Liz Moench, President and CEO If overwhelming evidence shows that positive reinforcement can affect worker behavior, what can it do for patients p...
By PharmaVoice Team • Jan. 2, 2008 -
Outsourcing Lessons in Clinical Success
Outsourcing VIEW on Clinical Services June 2006 BioCor Outsourcing Lessons in Clinical Success Niche CROs with stable project teams can offer operational excellence and strategic input. Lukas Makris, Ph.D., CEO Clinical excellence is a necessary component ...
By PharmaVoice Team • Jan. 2, 2008 -
Selecting and Implementing EDC-Enabled CDMS/CTMS -- When
The E-Arena VIEW on Clinical Services June 2006 Selecting and Implementing EDC-Enabled CDMS/CTMS — When “Should We?” Becomes “How Do We?” Timothy Pratt, Ph.D. Chief Marketing Officer and Principal Scientific Advisor In 2005, between 15% and 20% of all clinical trials in the...
By PharmaVoice Team • Jan. 2, 2008 -
Letter from the Editor
By Daniel Limbach Letter from the Editor VIEW on Clinical Services June 2006 Any mature industry would be pleased to have a double-digit annual growth trajectory for a year or two. Kalorama analysts predict that during the next five years, the growth of contract drug development will maintain...
By PharmaVoice Team • Jan. 2, 2008 -
The Critical Need for Clinical Performance Management
Clinical-Trial Management June 2006 VIEW on Clinical Services The Critical Need for Clinical Performance Management Bill Stevens Senior Director, Life Science Industry By investing in performance management software, organizations can leverage clinical information ...
By PharmaVoice Team • Jan. 2, 2008